Atara Biotherapeutics, Inc.
ATRA
$15.63
$1.6511.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 22.32M | 13.84M | 42.50M | 67.19M | 35.29M |
| Total Receivables | -- | 8.88M | 1.48M | 1.34M | 2.42M |
| Inventory | -- | -- | 10.66M | 13.98M | 18.75M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.45M | 4.47M | 10.26M | 9.35M | 5.95M |
| Total Current Assets | 24.77M | 27.18M | 64.89M | 91.86M | 62.41M |
|
|
|||||
| Total Current Assets | 24.77M | 27.18M | 64.89M | 91.86M | 62.41M |
| Net Property, Plant & Equipment | 11.20M | 32.01M | 41.10M | 47.49M | 51.27M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 927.00K | 2.84M | 3.10M | 3.36M | 3.61M |
| Total Assets | 36.90M | 62.04M | 109.10M | 142.71M | 117.28M |
|
|
|||||
| Total Accounts Payable | 1.76M | 1.38M | 4.37M | 2.15M | 5.25M |
| Total Accrued Expenses | 8.95M | 16.61M | 21.20M | 22.83M | 21.43M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.24M | 13.92M | 13.92M | 14.66M | 14.00M |
| Total Finance Division Other Current Liabilities | 1.61M | 15.98M | 95.09M | 116.34M | 107.58M |
| Total Other Current Liabilities | 1.61M | 15.98M | 95.09M | 116.34M | 107.58M |
| Total Current Liabilities | 14.56M | 47.89M | 134.57M | 155.98M | 148.27M |
|
|
|||||
| Total Current Liabilities | 14.56M | 47.89M | 134.57M | 155.98M | 148.27M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.43M | 28.03M | 31.52M | 35.24M | 38.70M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 41.95M | 41.19M | 40.29M | 42.02M | 41.18M |
| Total Liabilities | 71.94M | 117.11M | 206.38M | 233.25M | 228.15M |
|
|
|||||
| Common Stock & APIC | 1.98B | 1.96B | 1.96B | 1.95B | 1.91B |
| Retained Earnings | -2.01B | -2.02B | -2.05B | -2.04B | -2.02B |
| Treasury Stock & Other | -- | -- | 8.00K | 22.00K | -14.00K |
| Total Common Equity | -35.04M | -55.07M | -97.28M | -90.54M | -110.87M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.04M | -55.07M | -97.28M | -90.54M | -110.87M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -35.04M | -55.07M | -97.28M | -90.54M | -110.87M |
|
|
|||||